New approach aims to tame painful arthritis side effect of cancer drugs
NCT ID NCT06037811
Summary
This study is testing if starting a drug called adalimumab early can better control a painful arthritis that sometimes develops as a side effect of powerful cancer immunotherapy drugs. The main goal is to see if this approach helps patients reduce or stop their use of steroid medications, which have many side effects. About 30 adults who developed this arthritis while on cancer treatment will be randomly assigned to receive either adalimumab injections or the current standard steroid treatment to compare the results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St. Joseph's Health Care
RECRUITINGLondon, Ontario, N6A 4V2, Canada
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.